Watson acquiring generic company Specifar for $562 million in cash and up to €40 million ($56.1 million) in milestones

Specifar Pharmaceuticals S.A.

Greece / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Watson Pharmaceuticals Inc.

U.S. / Mid-Cap Biopharma ($1-$50 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed